Procurement Summary
Country : USA
Summary : Gene Targeting Vector Services through Ozgene Pty Ltd
Deadline : 26 Jul 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 69207597
Document Ref. No. : NOI-NIAID-2136123
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Gene Targeting Vector Services through Ozgene Pty Ltd
Active Contract Opportunity
Notice ID : NOI-NIAID-2136123
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office : NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 19, 2022 01:32 pm EDT
Original Response Date: Jul 26, 2022 05:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date:
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - MEDICAL- LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories
Place of Performance: Bethesda, MD 20892 USA
Description
PRE-SOLICITATION NOTICE - NOTICE OF INTENT
NOI-NIAID-2136123
NAICS - 541380, Testing Laboratories
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Ozgene Pty Ltd, located in Bentley, Australia, to procure gene targeting vector services to be used to investigate biologically relevant functions of JAK1 during defective mucosal immunity to C. albincans in STAT1 GOF.
The National Institute...
Documents
Tender Notice